The Long Run with Luke Timmerman podcast

Ep185: Dr. Lachelle Weeks on Predicting Leukemia Risk At Scale

17/9/2025

The Long Run with Luke Timmerman

0:00

1:05:47

Dr. Lachelle Weeks is a physician-scientist at Dana-Farber Cancer Institute working on a project to predict leukemia risk based on widely available blood samples.

Otros episodios de "The Long Run with Luke Timmerman"

Ep185: Dr. Lachelle Weeks on Predicting Leukemia Risk At Scale
hace 18 horas
1:05:47
Dr. Lachelle Weeks is a physician-scientist at Dana-Farber Cancer Institute working on a project to predict leukemia risk based on widely available blood samples.
Ep184: Jen Adair on Affordable, Accessible Gene & Cell Therapies
28/8/2025
1:50:23
Jen Adair, professor and associate director of the Horae Gene Therapy Center at the University of Massachusetts Chan Medical School, on creating more affordable and accessible cell and gene therapies.
No te pierdas ningún episodio de “The Long Run with Luke Timmerman”. Síguelo en la aplicación gratuita de GetPodcast.
Ep183: Sabah Oney on CAR-T Cells Against Solid Tumors
6/8/2025
56:23
Sabah Oney, CEO of Philadelphia and San Francisco-based Dispatch Biotherapeutics, on engineering CAR-T cells that can kill solid tumors.
Ep182: Andy Rachleff & Yung Lie on Creative Ways to Back Science
23/7/2025
1:01:18
Andy Rachleff and Yung Lie, board chair and CEO of Damon Runyon Cancer Research Foundation, on creative ways to support science amid budget cuts.
Ep181: Claire Mazumdar on a Two-Pronged Attack Against Cancer
1/7/2025
57:18
Claire Mazumdar, CEO of Boston-based Bicara Therapeutics, on developing a bifunctional antibody for head and neck cancer.
Ep180: John Rinn on Discovering Drugs Based on Long Non-Coding RNA
11/6/2025
1:10:45
John Rinn, professor at the University of Colorado and co-founder of Lincswitch Therapeutics, on exploring long non-coding RNA.
Ep179: Ethan Weiss & Josh Lehrer on a New Idea for Cardiovascular Disease & Diabetes
28/5/2025
1:03:25
Marea Therapeutics CEO Josh Lehrer and CSO Ethan Weiss on a new angle of attack against cardiovascular disease and diabetes.
Ep178: Peyton Greenside on ML-Guided Biologics Discovery
13/5/2025
1:02:56
Peyton Greenside, co-founder and CEO of BigHat Biosciences, on machine-learning guided biologic drug discovery.
Ep177: Kevin Parker on Finding Cancer Drug Targets
14/4/2025
58:13
Kevin Parker, CEO of Cartography Biosciences, on finding new cancer drug targets.
Ep176: David Roblin on Building a TechBio Company
31/3/2025
1:19:28
David Roblin, CEO of London-based Relation Therapeutics, on building a techbio discovery company.

Más episodios

Descubre los mejores podcast en la aplicación gratuita de GetPodcast.

Suscríbete a tus podcast favoritos, escucha episodios cuando estés sin conexión y déjate sorprender por las recomendaciones personalizadas.

Ep185: Dr. Lachelle Weeks on Predicting Leukemia Risk At Scale

The Long Run with Luke Timmerman

Otros episodios de "The Long Run with Luke Timmerman"

Ep185: Dr. Lachelle Weeks on Predicting Leukemia Risk At Scale

Ep184: Jen Adair on Affordable, Accessible Gene & Cell Therapies

Ep183: Sabah Oney on CAR-T Cells Against Solid Tumors

Ep182: Andy Rachleff & Yung Lie on Creative Ways to Back Science

Ep181: Claire Mazumdar on a Two-Pronged Attack Against Cancer

Ep180: John Rinn on Discovering Drugs Based on Long Non-Coding RNA

Ep179: Ethan Weiss & Josh Lehrer on a New Idea for Cardiovascular Disease & Diabetes

Ep178: Peyton Greenside on ML-Guided Biologics Discovery

Ep177: Kevin Parker on Finding Cancer Drug Targets

Ep176: David Roblin on Building a TechBio Company